Carregant...
Safety, Tolerability, and Clinical Effect of Low-Dose Buprenorphine for Treatment-Resistant Depression in Mid-Life and Older Adults
OBJECTIVE: Describe the clinical effect and safety of low-dose buprenorphine, a kappa-opioid receptor antagonist, for treatment-resistant depression (TRD) in mid-life and older adults. METHOD: Using an open-label protocol, buprenorphine was prescribed for 15 adults age 50 and older with TRD, diagnos...
Guardat en:
| Autors principals: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2014
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4157317/ https://ncbi.nlm.nih.gov/pubmed/25191915 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4088/JCP.13m08725 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|